Similarly, in a model of tauopathy, the microgliosis elicited by mutant tau can be prevented pharmacologically by Nrf2 inducers such as DMF [79], whereas the effect is lost in Nrf2-/- animals. This evidence concerns the gene MAPT and tauopathy.